AA |
arachidonic acid |
ACS |
acute coronary syndrome |
ADP |
adenosine diphosphate |
ATP |
adenosine triphosphate |
ApoER2 |
apolipoprotein E receptor 2 |
APP |
amyloid precursor protein |
Aβ |
amyloid beta |
CAD |
coronary artery diseases |
CCR1 (3, 4) |
C-C chemokine receptor type 1 (3, 4) |
CLEC |
C-type lectin-like receptor |
CNS |
central nervous system |
CVD |
cardiovascular diseases |
CXCL11 (12, 16) |
C-X-C motif chemokine ligand 11 (12, 16) |
DEP |
diesel exhaust particles |
DP1
|
prostaglandin D2 receptor 1 |
DVT |
deep vein thrombosis |
DTS |
dense tubular system |
EC |
endothelial cells |
EP1-4
|
prostaglandin E2 receptors 1-4 |
Erk |
extracellular stimuli-responsive kinase |
GPCR |
G-protein-coupled-receptors |
GPIb |
glycoprotein Ib |
GPO |
glycine-proline-hydroxyproline |
GPVI |
glycoprotein VI |
IL-6 |
interleukin-6 |
ITAM |
immunoreceptor tyrosine-based activation motif |
LAD |
left anterior descending artery |
LAT |
linker for the activation of T cells |
MI |
myocardial infarction |
MIF |
macrophage migration inhibitory factor |
MK |
megakaryocytes |
NMDAR |
N-methyl-D-aspartate receptor |
oxLDL |
oxidized low density lipoprotein |
PA |
phosphatidic acid |
PANX1 |
pannexin-1 |
PDI |
protein disulfide isomerase |
PGD2
|
prostaglandin D2
|
PGE2
|
prostaglandin E2
|
PGI2
|
prostaglandin I2
|
PKC |
protein kinase C |
PLATO |
Platelet Inhibition and Patient Outcome |
PLCγ2 |
phospholipase Cγ2 |
PLD |
phospholipase D |
Prb |
probenecid |
PS |
phosphatidylserine |
SAP |
stable angina pectoris |
SDF-1 |
stromal cell-derived factor 1, CXCL12 |
SFK |
Src family kinases |
SR |
scavenger receptor |
TP |
TXA2 receptor |
TxA2 |
Thromboxane A2
|
VLDLR |
very low density lipoprotein receptor |
vWF |
von Willebrand factor |